You are here

Merck

As rival Merck monopolizes BCG supply, ImmunityBio taps Serum Institute for new combo's manufacturing

Fierce Pharma

Mon, 05/6/24 - 11:30 am

Merck reports data from Phase III gastric cancer treatment trial

Clinical Trials Arena

Thu, 05/2/24 - 11:23 am

clinical trials

Pfizer takes top spot in docs' vaccine ranking by 'huge margin'

Fierce Pharma

Wed, 05/1/24 - 09:35 am

Moderna Therapeutics

On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23

Fierce Biotech

Mon, 04/29/24 - 10:50 pm

pneumococcal disease

Merck Gets Q1 Beat as Sales of Cancer Blockbuster Keytruda Jump 20%

BioSpace

Thu, 04/25/24 - 11:41 am

AstraZeneca’s Lynparza to remain dominant in PARP inhibitors market with $4 billion in sales by 2027

Biopharma Reporter

Thu, 04/25/24 - 11:36 am

PARP inhibitors

Biopharma M&A more than doubled in the first quarter compared to the year prior: report

Fierce Biotech

Thu, 04/18/24 - 11:11 am

Harpoon Therapeutics

Merck Paid $208 Million to Stop Its Drugs From Working

Motley Fool

Sun, 04/14/24 - 01:27 pm

antibody-drug conjugate

With 9% pay hike, Merck CEO Robert Davis entered $20M compensation club in 2023

Fierce Pharma

Sun, 04/14/24 - 01:20 pm

executive compensation

AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer

BioSpace

Wed, 04/10/24 - 09:59 am

antibody-drug conjugate

clinical trials

Moderna jumps as vaccine shows benefit in head and neck cancer in early study

Reuters

Tue, 04/9/24 - 05:43 pm

Moderna Therapeutics

clinical trials

head and neck cancer

Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS

BioSpace

Fri, 04/5/24 - 11:42 am

clinical trials

KRAS inhibitors

non-small lung cancer

Daiichi Sankyo and Merck dose first subject in ovarian cancer trial

Clinical Trials Arena

Thu, 04/4/24 - 10:53 am

clinical trials

raludotatug deruxtecan

'We're open for business': FDA's Peter Marks says agency ready to review novel cancer vaccines despite unknowns

Fierce Biotech

Wed, 04/3/24 - 10:30 pm

Moderna Therapeutics

EU Approves Merck’s Keytruda, Chemo Combo for Lung Cancer

BioSpace

Thu, 03/28/24 - 04:56 pm

non-small cell lung cancer

Merck scores key FDA approval for pulmonary arterial hypertension drug Winrevair

Fierce Pharma

Wed, 03/27/24 - 11:22 am

Merck’s next big thing is (probably) on the way

Stat

Tue, 03/26/24 - 11:03 am

Merck, Others Look to Immunotherapy Combos as Next Frontier in Oncology

BioSpace

Mon, 03/25/24 - 11:32 am

Padcev, Keytruda, and Balversa leave little room for Opdivo in urothelial carcinoma

Clinical Trials Arena

Thu, 03/21/24 - 06:41 pm

urothelial cancer

Bristol Myers Squibb

Merck combination treatment for lung cancer fails late-stage study

Reuters

Thu, 03/21/24 - 11:13 am

non small cell lung cancer

Pages